fig1

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Figure 1. Gut microbiome and the immune system. SCFAs: Short-chain fatty acids; PD-L1: programmed death ligand 1.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/